The global high flow ventilators market size was valued at USD 1,809.73 million in 2022. It is estimated to reach USD 3,057.50 million by 2031, growing at a CAGR of 6.02% during the forecast period (2023–2031).
The flourishing prevalence of respiratory diseases like asthma, COPD, pneumonia, and other respiratory diseases is expected to boost the market growth. The geriatric population is highly prone to these diseases, and the soaring geriatric population is also expected to drive market growth.A ventilator is a type of breathing apparatus, a medical technology category that provides mechanical ventilation to a patient who is physically not able to breathe or breathing insufficiently. A ventilator delivers oxygen to the lungs, aids in the elimination of carbon dioxide (CO2) from the airways, and provides pressure to prevent the alveoli (small air sacs in the lungs) from contracting.
A modern positive pressure ventilator consists of a compressible air reservoir or turbine, valves and tubes, air and oxygen supplies, and a disposable or reusable "patient circuit" in its basic configuration. Ventilators may be computerized, microprocessor-controlled machines, but patients can also be ventilated using a manual bag valve mask. Ventilators are primarily utilized in intensive care, home care, emergency medicine (as standalone units), and anesthesia (as a component of an anesthesia machine).
|Market Size||USD 3,057.50 million by 2031|
|Fastest Growing Market||Europe|
|Largest Market||North America|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends|
The prevalence and incidence of respiratory illness are rising, and the global prevalence of the diseases is expected to grow. The prevalence of work-related asthma is higher among this target population, which includes those who work in factories that produce drugs and antibiotics and who report breathing problems. For instance, in 2019, doctors who participated in the SWORD (Surveillance of Work-Related and Occupational Respiratory Diseases) scheme within the Health and Occupation Reporting (THOR) network in the United Kingdom estimated 174 new cases of occupational asthma.
Additionally, according to the November 2021 article "Association of Chronic Lower Respiratory Disease With County Health Disparities in New York State," chronic lower respiratory disease (CLRD) is the fourth leading reason of death in the U.S., and approximately 14.8 million people have been diagnosed with COPD. More than 25 million people have had asthma recently. Therefore, the statistics above show that the prevalence of respiratory diseases is increasing globally, driving the demand for high-flow ventilators to provide oxygen therapy to patients and overcome breathing issues, thereby driving the market's growth.
The geriatric population is more susceptible to age-related diseases that are less prevalent among the young. The geriatric population is likelier to suffer from chronic obstructive pulmonary disease, asthma, pulmonary fibrosis, pneumonia, and other age-related respiratory diseases. In addition, the world is expected to witness a demographic shift over a few decades, and the geriatric population is expected to dominate. The United Nations Department of Economic and Social Affairs report titled 'World Population Ageing 2020 Highlights' mentioned that there were 727 million persons aged 65 years or older in the world in 2020. It is expected to more than double and reach nearly 1.5 billion in 2050. Since the older population is at high risk of getting respiratory and other illnesses, it is expected to generate the need for high-flow ventilators, driving the market's growth.
COPD is increasing the disease burden globally. COPD has a major negative influence on quality of life, including limiting the ability to work, normal physical exertion, household chores, social and family activities, and sleeping patterns. Despite the presence of robust insurance coverage for patients, the cumulative costs associated with health and prescription deductibles, copays, and coinsurance premiums can accrue significantly when selecting respiratory or lung disease treatment options.
The "European Lung White book" published its chapter named "The Economic Burden of Lung Disease" and reviewed it in January 2022, mentioning that the total cost of respiratory disease in the 28 nations of Europe alone amounts to more than EUR 380 billion annually. Hence, the factors above show that respiratory diseases greatly impact the economy. This may hamper the global demand for flow through oxygen therapies, restraining the high flow through ventilators market growth over the forecast period.
The increasing geriatric population, coupled with rapidly rising respiratory diseases, demands the availability of advanced ventilators for patient survival. The global commercial landscape for product development and innovation is seeing fast expansion, necessitating the utilization of advanced technology in critical care. To minimize the risks of hyperoxia and associated complications caused by the inaccurate administration of oxygen, Hamilton Medical ventilators offer a continuous display of all relevant monitoring parameters for high-flow oxygen therapy, such as oxygen concentration, flow rates, SpO2 (optional), humidifier temperature, and trends.
Additionally, in October 2021, Movair, a company specializing in respiratory therapy, released Luisa, an advanced ventilator designed for invasive and non-invasive ventilation in homes, institutions, hospitals, and portable applications. This advancement of technology in the ventilators segment developed by major players creates demand for high-flow ventilators for critical care use, creating opportunities for market growth.
Based on region, the global high flow ventilators market is bifurcated into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa.
North America is the most significant global high flow ventilators market shareholder and is anticipated to exhibit a CAGR of 5.54% during the forecast period. The region's increasing geriatric population and rising incidence of respiratory diseases are the key market drivers. The increase in the number of initiatives undertaken by government and non-government organizations contributes to an increase in total revenue. For example, the CDC's National Asthma Control Program (NACP) funds asthma patient education. Such initiatives are likely to elevate awareness about asthma and increase the adoption of equipment to treat asthma, leading to vertical growth. In addition, many regional companies are launching new products or entering into strategic initiatives to boost their market share. For instance, in March 2021, Getinge Canada launched its version 4.0 software available for the Servo-u intensive care ventilator. Version 4.0 offers transpulmonary pressure monitoring and auto lung recruitment maneuvers for personalized lung protection and weaning. Therefore, owing to the factors above, the high flow ventilators market is expected to witness steady growth in North America during the forecast period.
Europe is estimated to exhibit a CAGR of 5.78% over the forecast period. The increasing demand for high flow ventilators due to the rise in respiratory diseases and the surging number of surgeries is expected to drive the market. As per the Germany Federal Statistical Office 2020 report, the population of Germany is about 83 million. There are about 16.2 million people above the age of 67, projected to reach 21.4 million by 2040. In addition, the soaring geriatric population in the country also supports market expansion. For instance, as per the Office for National Statistics Report in January 2022, in the ten years leading up to mid-2030, the population of the United Kingdom, which was estimated to be 67.1 million, is expected to increase by 2.1 million to 69.2 million (3.2% increase). Thus, the growing geriatric population is highly susceptible to chronic respiratory diseases and requires surgical interventions and treatment, thereby boosting regional market growth.
The Asia-Pacific region is the fastest-expanding region in the market. The major factors driving the growth of the Asia-Pacific high-flow ventilators market include the flourishing burden of respiratory diseases, a surge in the geriatric population, and a huge patient pool. Similarly, several regional manufacturers are launching ventilators to increase their consumer base. For instance, in April 2020, the Nihon Kohden Group received approval for producing and marketing the NKV-550 series ventilator in Japan. A smooth transition between invasive and non-invasive ventilation and high-flow oxygen therapy optimizes the clinician's workflow. In April 2020, a collaborative effort between the Indian Institute of Technology (IIT)-Roorkee and the All India Institute of Medical Science (AIIMS), Rishikesh, resulted in the development of an affordable ventilator. The ventilator, Prana Vayu, costs INR 25,000 per unit. Therefore, the market is expected to significantly expand during the forecast period because of the abovementioned factors.
In South Africa, factors such as the growing burden of respiratory disorders, increasing focus on research and development, and growing technological advancement fuel the market's growth. As per the World Health Organization (WHO), as of 21st June 2021, there were 928,919 confirmed cases of COVID-19, with 2,309 deaths, in the United Arab Emirates. According to an article published in the Society of Critical Care Medicine and Wolters Kluwer Health, 2019, the estimated prevalence of prolonged home ventilation was high in Saudi Arabia. Hence, this helps the growth of the overall market for ventilators.
Smoking increases the risk of developing respiratory disorders in people with serious smoking habits. Therefore, the number of smokers in the region is expected to fuel the market's growth. For instance, the estimated number of tobacco consumers (in thousands) in South Africa is approximately 8,537 (7,120 males and 1,418 females), according to the fourth edition of the WHO global report on changes in the prevalence of tobacco use 2000–2025.
The global high flow ventilators market is segmented by modality and end-user.
Based on modality, the global high flow ventilators market is divided into portable high flow ventilators and trolley-mounted high-flow ventilators.
The trolley-mounted high-flow ventilators segment is the largest revenue contributor to the market and is expected to exhibit a CAGR of 6.19% throughout the forecast period. Trolley-mounted high flow ventilators help deliver safe and gentle intensive care unit ventilation performance, even during intrahospital transport. Factors such as the growing burden of emergency department admission owing to increasing respiratory and other disease burdens, advancements in technology in the product, and the launch of products by market players are propelling the growth of the trolley-mounted high flow ventilators segment of the studied market over the forecast period.
In addition, the strategies adopted by the market players, such as incorporating technologically advanced solutions in a trolley-mounted high-flow ventilator to provide better care, also propelled the market segment's growth. For instance, in December 2021, Hamilton Medical launched a new HAMILTON-C6 software and user interface, SW v1.2.1. The new version will provide higher flow rates in HiFlowO2 for all patient groups, and the HiFlowO2 humidification mode is enabled directly from the ventilator.
Portable high-flow ventilators are compact devices designed to provide ventilation where piped gases and mains electricity are unavailable. This helps in giving high-flow oxygen therapy, which is non-invasive respiratory support that delivers warmed, humidified, oxygen-enriched air to patients. Portable high-flow ventilators are devices that enable a high level of sophistication compared to that of a conventional intensive care ventilator. In addition, factors such as the growing burden of respiratory diseases, the launch of products, and research studies demonstrating the benefits of devices leading to enhanced adoption are expected to drive the growth of portable high-flow ventilators over the forecast period. The growing burden of respiratory diseases in different regions is also expected to propel the demand for segmentation.
Based on the end-user, the global high flow ventilators market is segmented into hospitals, ambulatory surgical centers, and other end-users.
The hospitals segment owns the highest market share and is estimated to exhibit a CAGR of 5.96% during the forecast period. Hospitals are equipped with advanced technological equipment for surgical procedures and improved treatments. The hospital segment is witnessing rapid growth, owing to the growing number of surgeries due to various infectious and chronic diseases, the increasing number of hospitals, and the launch of new products by the market players. These factors will continue, driving the segment's growth over the forecast period. The soaring number of hospital admissions and admissions in the intensive care unit necessitates the utilization of high flow ventilators. The approvals from the regulatory body in different regions are also expected to expedite the market growth studied. For instance, in April 2021, Getinge AB received clearance for the Servo-u MR in the United States market, a complement to the Servo.
Ambulatory surgery centers (ASCs), also known as outpatient surgery, day surgery, or same-day surgery, are modern healthcare facilities that offer same-day surgical care, including diagnostic and preventive procedures that do not need an overnight stay in the facility. Since high-flow ventilators are used in different types of surgeries, a rising number of ambulatory surgical centers is expected to drive the market segment's growth. Factors such as the rising burden of diseases and an increasing number of ambulatory surgical centers are expected to expedite the market segment's growth over the forecast period.